DJIA 17,440.59 -127.94 -0.73%
NASDAQ 5,039.78 -48.85 -0.96%
S&P 500 2,067.64 -12.01 -0.58%
market minute promo


1.70 -0.06 (-3.41%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VVUS $1.70 -3.41%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.79
Previous Close $1.76
Daily Range $1.68 - $1.82
52-Week Range $1.68 - $5.13
Market Cap $176.5M
P/E Ratio -2.20
Dividend (Yield) $0.00 (0.0%)
Volume 1,355,328
Average Daily Volume 989,879
Current FY EPS -$0.83




Drug Makers

VIVUS, Inc. (VVUS) Description

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website:

News & Commentary Rss Feed

Obesity Statistics Take a Wrong Turn in This Latest Study

Obesity, the silent killer, costs the global economy $2 trillion annually. Find out what tactics could be used to help curb rising obesity levels.

Vivus: Weight Loss Sector Or Erectile Dysfunction - Pick Your Poison

Orexigen: Contrave Sales Up 2.75% - Still No News On Europe

EnteroMedics - De-Listing Process Should Be Front And Center With Investors

Vivus- Qsymia Sales Trending Down Again

Arena: Belviq Sales Slide Continues- Will Eisai Step Up To The Plate?

Orexigen- Contrave Sales Dip Despite Market Leadership

Arena Closes Out Quarter On Belviq Sales - How Do The Numbers Look?

Stocks Hitting 52-Week Lows

Orexigen: Contrave Sales Win The Week, Pace Still Slower Than Needed

Arena - Belviq Sales Slide Again

See More VVUS News...

VVUS's Top Competitors

VVUS $1.70 (-3.41%)
Current stock: VVUS
NVS $101.54 (-0.26%)
Current stock: NVS
PFE $34.34 (0.23%)
Current stock: PFE
JNJ $98.28 (-0.88%)
Current stock: JNJ